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Abstract
Purpose: This is to evaluate the effects of age and different concentrations of pilocarpine on tear 
 ow rate and pupil size.
Methods: The tear flow rates and pupil sizes of eighty-one volunteers were measured with 
Schimer’s strips and a meter rule gauge, respectively. These procedures were also employed in 
testing the effects of 2 % and 4 % concentrations of pilocarpine on tear secretion and pupil 
constriction.
Results: There were signi cant differences between the initial mean tear  ow rate and the mean 
tear  ow rates after the installation of 2 % pilocarpine (critical t = 1.96 and calculated t = 6.46) 
and 4 % pilocarpine (calculated t = 8.83). There were no signi cant differences in the initial tear 
 ow rates between the sexes. There were signi cant differences between the mean tear  ow 
rates obtained with 2 % and 4 % concentrations of pilocarpine (calculated t = 3.41). The mean 
initial tear  ow rate for the eighty-one volunteers was 13.84 mm ± 1.19 (SD).There were signi cant 
differences between the mean initial pupil size 2.96 mm ± 1.04 (SD) and the mean pupil sizes 
2.38 mm ± 1.11(SD) after the instillation of 2 % pilocarpine (Critical t = 1.96 and calculated 
t = 2.46).
Conclusion: The basal tear flow rate decreased with advancing age and topical pilocarpine 
increased tears secretion in all the age groups. The age groups (31 years and above) were more 
tolerant to the stinging effect of pilocarpine and induced reduced pupil sizes, but there were no 
significant differences between the mean pupil sizes obtained with the pilocarpine 
concentrations.
© 2009 Spanish General Council of Optometry. Published by Elsevier España, S.L. All rights reserved.
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Introduction
Pilocarpine eye drop is mainly employed in the treatment of 
glaucoma and it causes pupil constriction. The eye drop 
causes temporary blur vision that last for 2 to 3 hours 
following topical instillation. 1 Pilocarpine, a tertiary amine, 
belongs to a group of drugs called parasympathomimetics 
and was reported to be available in concentrations exceeding 
4 %. However, there was usually no advantage in using 
such higher concentrations except in black patients and 
in patients with very dark pigmented rides. 2,3 Topical 
pilocarpine concentrations higher than 4 % are not readily 
available in Nigeria. Therefore 2 % and 4 % concentrations 
produced by Martindale Pharmaceuticals Limited, England, 
were purchased for this study because of their availability.
Oral and intravenously injected pilocarpines had been 
employed in the stimulation of salivary and lacrimal glands 
for higher secretions. They were found useful in the 
treatment of dry eye patients, but had some measures of 
systemic adverse effects. 4-6 Thus pilocarpines served as a 
temporary remedy in alleviating the sufferings of dry-eyed 
patients. Tsifeteki et al. 6 employed oral pilocarpine for their 
study and found significant improvement on dry eye 
patients, but did not substantiate if there was an increase in 
tear secretion. Tomlison et al. 7 reported that the volume of 
tears in the eye was dependent on the rate of production, 
elimination, drainage and evaporation of tears. From these 
reports it could be deduced that advancing age might be a 
factor to be considered. Masahiko and Hsiao-Fu 8 revealed 
that the rate of tear secretion decreased with advancing 
age. Lambert et al. 9 argued that there was no decrease in 
tear production with advancing age and their result revealed 
no significant differences between the males and the 
females in the study. However, they 9 observed 40 % reduction 
in the mean tear  ow rate (MTFR) measured with Shirmer’s 
strip before and after the application of anesthetic. Several 
authors 10-12 reported that the prevalence of dry eye increased 
progressively with age, and individuals between 31 to 
40 years and above age were at a higher risk.
The effects of topically instilled pilocarpine on tear  ow 
rate and pupil size have not been extensively documented 
and topical pilocarpine has for a long time been employed 
in the treatment of glaucoma patients with no major 
systemic side effect. Topical pilocarpine might be useful as 
a temporary remedy for tear volume related dry eyes, if 
found to stimulate sustained tear secretion. Therefore the 
effects of topical pilocarpine concentrations on pupil size 
and tear flow rate of healthy eyes of black Africans in 
different groups of age and gender were determined.
Methods
Teenagers and adults between 10 to 50 years of age were 
recruited from the population of University of Benin, Benin 
city, Nigeria. This study on human subjects was conducted in 
accordance with the tenets of the declaration of Helsinki. 
Verbal and written consents were obtained from the 
volunteers, after explanation of the project procedures. All 
potential volunteers underwent partial eye examination in 
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Resumen
Objetivo. Evaluar los efectos del envejecimiento y de diferentes concentraciones de un colirio de 
pilocarpina sobre la tasa de secreción lagrimal y el tamaño pupilar.
Métodos. Se determinaron las tasas de secreción lagrimal y el tamaño pupilar en 81 individuos 
voluntarios mediante una tira de Schirmer y un pupilómetro junto con una regla transparente mi-
limetrada, respectivamente. Estos procedimientos también se usaron para analizar los efectos de 
concentraciones de un colirio de pilocarpina al 2 y al 4 % sobre la secreción lagrimal y la constric-
ción pupilar.
Resultados. Se identi caron diferencias signi cativas entre la tasa media inicial de secreción la-
grimal y las tasas medias después de la instilación de colirio de pilocarpina al 2 % (t crítica = 1,96 y 
t calculada = 6,46) y al 4 % (t calculada = 8,83). No hubo diferencias signi cativas en las tasas de 
secreción lagrimal inicial entre sexos. Se detectaron diferencias signi cativas entre las tasas me-
dias obtenidas con la concentración de pilocarpina al 2 y al 4 % (t calculada = 3,41). La tasa inicial 
media de secreción lagrimal de los 81 individuos fue de 13,84 mm ± 1,19 (DE). Hubo diferencias 
signi cativas entre el tamaño pupilar inicial medio (2,96 mm ± 1,04 [DE]) y el tamaño pupilar 
medio (2,38 mm ± 1,11 [DE]) tras la instilación de colirio de pilocarpina al 2 % (t crítica = 1,96 y t 
calculada = 2,46).
Conclusión. La tasa basal de secreción lagrimal disminuyó con la edad avanzada y el colirio de 
pilocarpina aumentó la secreción lagrimal en todos los grupos de edad. Los grupos de edad de 
31 años en adelante fueron más tolerantes al escozor provocado por la pilocarpina y la disminu-
ción inducida del tamaño pupilar, pero no hubo diferencias signi cativas entre los tamaños medios 
obtenidos con las diferentes concentraciones de pilocarpina.
© 2009 Spanish General Council of Optometry. Publicado por Elsevier España, S.L. Todos los derechos 
 reservados.
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order to rule out ocular infections, dry eye symptoms and 
significant refractive errors (errors more than ± 1.5 DS, 
including the spherical equivalent of the cylinder lens). 
Volunteers with suspected epiphoria, binocular problems, 
observable ocular diseases and reports of drug allergies or 
sensitivity to the preservative Benzalkonium chloride were 
eliminated from the study. A total of 140 volunteers were 
examined for the project, but 81 participants, consisting of 
51 (63 %) males and 30 (37 %) females met the selection 
criteria. The range of age of the 81 selected subjects was 
between 10 and 45 years and the subjects were divided into 
four groups of age: 10-20, 21-30, 31-40, and 41-50 (Table 1).
Two independently trained persons graded the iris colours 
of the participants by employing Seddon et al. 13 methods of 
classi cation, using the set of available standard photographs. 
Iris was graded under natural daylight as the subjects  xate 
at distant object. For this study, grades 1 to 3 were 
considered as light iris colour, while grades 4 and 5 were 
considered as brown to dark iris.
All the participants that met the criteria for selection had 
brown to dark irises. The vertical pupil diameter size of the 
participant’s right eye was measured with a hand held gauge 
marked in millimeters, before and after the instillation of 
the eye drops. The vertical pupil diameter measured before 
the commencement of instillation of pilocarpine was the 
control experiment. An average of three readings of the 
vertical pupil diameter was recorded for each subject 
before and after the instillation of pilocarpine.
The volume of pilocarpine was determined by measuring a 
total of 1,000 drops from 5 different bottles using a micro 
liter syringe (100 ml). The observed mean volume of the 
drops from all the  ve bottles was 29.5 ml, ± 4.96. The mean 
drop volumes from the different bottles were 30.3 ml, 
29.5 ml, 29.1 ml, 28. 7 ml and 29.4 ml. The droppers (10 ml) 
with the concentrations of pilocarpine to be tested were 
given to each participant for instillation of pilocarpine, one 
drop was applied twice daily for three days on the right eye. 
Therefore each individual had a measured minimum of about 
28.7 ml drop volume instilled twice daily into the right eye. 
The participants were thought to occlude the puncta for 
three minutes, immediately after the instillation of one drop 
of pilocarpine. This precaution was adopted to avoid as much 
as possible direct systemic absorption of the drug. The 
participants were asked to visit the clinic daily between 
4 pm. and 6 pm, in order to monitor their tolerance for 
pilocarpine and to administer the last one drop for the day. 
The time 4 pm to 6 pm was adopted for convenience in order 
to avoid busy hours of the clinic. This was also to ensure that 
each participant had at least one drop of pilocarpine instilled 
daily and for precautionary reasons. At the end of the third 
day between 4 pm. and 6 pm pupil sizes were evaluated and 
the Schirmer’s strips were employed for the measurements 
of tear flow rates of the participants. All the subjects 
complied with the instructions and procedures.
The initial tear  ow rates and pupil sizes of the volunteers 
were measured before the commencement of instillation of 
2 % pilocarpine for three days. The measurements of the 
initial tear  ow rates and pupil sizes were for the control 
experiment. A period of two weeks of rest was allowed for 
each subject after the three days of administration of 2 % 
pilocarpine. The instillation of 4 % pilocaropine commenced 
immediately after the two weeks of rest. The procedure 
was repeated with 4 % pilocarpine. The 2 % and 4 % pilocarpine 
concentrations employed in this study were produced by 
Martindale pharmaceutical in England. The eye drops were 
sterile solution of pilocarpine hydrochloride BP containing 
purified water and Benzalkonium chloride 0.01 % as a 
preservative.
After three days of instilling the eye drop, measurements 
for tear  ow rates and pupil size were carried out between 
the hours of 4pm. and 6pm. The inferior cul-de-sac was 
blotted with tissue paper, in order to remove the already 
accumulated reflex tears, before the bent tip of the 
standardized Schirmer’s strip was placed at the lateral 1/3 of 
the lower eyelid of each volunteer. The volunteer being 
tested with Schirmer’s strip was instructed to look forward 
and blink normally. The strip was removed after 5 min. and 
the amount of wetting (tear flow rate) was recorded in 
millimeters. The average of three readings was recorded for 
each subject during the measurement of tear rates and pupil 
sizes. The pupil sizes and the tear  ow rates measurements 
obtained for each group of age were presented in means and 
standard deviations. The statistical significance between 
controls and trials was estimated using two tailed t test set at 
0.05 con dence level and P < .05 was considered signi cant.
Results
In the study population, the average age for the males was 
28.59 ± 7.51 (SD) years and the mean age for the females 
was 29.89 ± 7.01 (SD) years. The mean age for the total 
population examined was 29.06 ± 7.34 (SD) years. The mean 
basal (or initial) tear  ow rate (IMTFR) for the eighty-one 
volunteers was 13.84 mm ± 1.20(SD). Many of the volunteers 
selected were between 21 and 40 years of age as shown in 
Table 1.
The initial mean tear flow rate (IMTFR) value for the 
female participants was 13.48 ± 1.34 (SD) and the males had 
initial mean tear  ow rate (IMTFR) of 13.98 mm ± 1.22 (SD). 
There were no signi cant differences between the initial 
tear flow rates (IMTFR) of the male and the female 
participants (critical t = 1.96 and calculated t = 1.72), using 
two-tail t test, at 0.05 con dence level.
The initial mean tear flow rate (IMTFR) values for the 
different groups of age decreased with increase in age in 
both the males and the females. In Table 2, the differences 
between the mean tear flow rates (MTFR) for different 
groups of age and genders were reduced after applying two 
and four percent concentrations of pilocarpine. There were 
Table 1 Population distribution of gender within 
the groups of age
Age groups 
in years
Males Females Total
10-20  9 (17.7 %)  4 (13.3 %) 13 (16.1 %)
21-30 22 (43.1 %) 10 (33.3 %) 32 (39.5 %)
31-40 17 (33.3 %) 14 (46.7 %) 31 (38.3 %)
41-50  3 (5.9 %)  2 (6.7 %)  5 (6.2 %)
Total 51 (63 %) 39 (37.0 %) 81 (100 %)
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no signi cant differences between the males and the females 
tested with either 2 % or 4 % pilocarpine concentrations 
(Critical t = 1.96, calculated t for 2 % pilocarpine = 1.41 and 
calculated t for 4 % pilocarpine = 0.83), using two-tailed t 
test. The mean tear  ow rate value for males in the group of 
age between 10-20 years was higher in proportion than that 
observed in the females in the same group; this trend was 
observed in all the groups of age, but had no statistical 
signi cance. The observed differences in the mean tear rate 
values between the genders in the different groups of age 
were maintained before and after the administration of the 
pilocarpine concentrations. The subjects complained about 
slight transient blurred vision after the topical instillation of 
pilocarpine into the right eye. However, there was no other 
serious complaint from the participants except for the slight 
red eye and stinging experience after the instillation of 
pilocarpine.
The initial mean tear  ow rate (IMTFR) for the participants 
was 13.84 mm ± 1.20 (SD) and the mean tear  ow rate value 
after the application of 2 % pilocarpine was 15.08 mm ± 144 
(SD). There were signi cant differences between the mean 
initial tear  ow rate value and the mean tear  ow rate value 
after the instillation of 2 % pilocarpine (Critical t = 1.96 
calculated t = 6.46), using t test at 0.05 con dence level. 
The mean tear flow rate value for 4 % pilocarpine was 
15.87 mm ± 2.00 (SD). There were signi cant differences 
between 2 % and 4 % concen trations of pilocarpine (critical 
t = 1.96 and calculated t = 3.4) (Table 3).
The participants in the group of age 10 to 20 years had 
higher initial mean tear  ow rate (IMTFR) values than others 
in the groups of age between 31 to 50 years. The initial mean 
tear  ow rate of the participants in the 10 to 20 group of age 
was compared statistically with the IMTFR of 41 to 50 years 
group of age and it was found that there were significant 
differences between the two groups of age (Critical 
t = 1.71 and calculated t = 3.08), using two- tailed t test at 
0.05 con dence level. The initial mean tear  ow rate value 
14.25 mm ± 0.48 of volunteers in the 10 to 20 years group of 
age was similar to the value 14.32 ± 1.33 observed after the 
treatment with 2 % pilocarpine of volunteers in the age group 
41 to 50 years; there were no statistical signi cant differences 
between the two values (critical t = 1.96 calculate t = 0.18), 
using two- tailed t test, at 0.05 con dence level. The mean 
tear  ow rate (MTFR) values obtained after treatment with 
4 % pilocarpine for the groups of age 10-20 and from 41 to 
50 were 16.26 mm ± 1.73 and 15.21 mm ± 1.76, respectively. 
There were also no signi cant differences between the mean 
tear flow rates of the volunteers in groups of age 10 to 
20 years and 41 to 50 years after the instillation of 4 % 
pilocarpine (Critical t = 1.96, calculated t = 1.21), using 
two-tailed t test statistics.
There were no signi cant differences in the mean pupil sizes 
between 2 % and 4 % pilocarpine concentrations after the 
instillations (calculated t = 1.059, critical t = 1.96), using two 
tailed t test at 0.05 confidence level. However, there were 
significant differences between the mean initial pupil size 
2.93 mm ± 1.04 (SD) and the mean pupil size after the instillation 
of 2 % pilocarpine 2.3 mm ± 1.11(SD), (critical t = 1.96 and 
calculated t = 2.46), using t test statistics (Table 4).
Discussion
There are two kinds of tears production, which can be 
distinguished from each other, the basic and re ex secretion. 
The diagnostic tests presently available are limited mainly 
Table 2 Mean tear  ow rate (MTFR) for the different groups of age and gender
Age group 
in years
Initial mean tear  ow
 rates for (IMTFR)
Mean tear  ow rate (MTFR) 
with 2 % pilocarpine for
Mean tear  ow rate 
with 4 % pilocarpine for
 Females Males Females Males Females Males
10-20 14.00 ± 1.12 14.48 ± 0.7 14.32 ± 2.31 15.80 ± 0.82 15.21 ± 2.92 16.63 ± 0.97
21-30 13.00 ± 1.08 13.68 ± 1.91 14.56 ± 1.27 15.25 ± 1.60 15.61 ± 1.38 16.00 ± 1.67
31-40 13.88 ± 1.09 13.93 ± 1.07 15.14 ± 1.46 14.92 ± 1.50 16.04 ± 1.88 15.71 ± 1.47
41-50 12.50 ± 0.71 12.60 ± 1.57 13.88 ± 0.177 14.50 ± 1.58 14.25 ± 0.35 15.55 ± 2.02
Total MTFR 13.48 ± 1.34 13.94 ± 1.22 14.45 ± 1.35 14.96 ± 1.62 15.26 ± 1.66 15.82 ± 1.45
Table 3 Mean tear  ow rate with 2 % and 4 % pilocarpine 
in different groups of age
Age group 
rate 
in years
Initial 
mean tear 
 ow rates
Mean tear 
 ow rate with 
2 % pilocarpine
Mean tear 
 ow with 
4 % pilocarpine
10-20 14.25 ± 0.48 15.45 ± 1.44 16.26 ± 1.73
21-30 13.47 ± 1.50 14.96 ± 1.47 15.81 ± 1.51
31-40 13.90 ± 1.06 15.02 ± 1.46 15.86 ± 1.64
41-50 12.57 ± 1.27 14.32 ± 1.33 15.21 ± 1.76
Total 13.84 ± 1.20 14.95 ± 1.43 15.79 ± 1.66
Table 4 Mean pupil sizes before and after instillations 
of 2 % and 4 % pilocarpine
Age 
group i
n years
Initial 
mean pupil 
size
Mean pupil 
sizes with 
2 % pilocarpine
Mean pupil 
sizes with 
4 % pilocarpine
10-20 3.86 ± 0.48 2.85 ± 1.44 2.65 ± 1.73
21-30 2.68 ± 1.33 2.27 ± 1.47 2.25 ± 1.61
31-40 2.64 ± 1.06 2.18 ± 1.36 2.20 ± 1.64
41-50 2.64 ± 1.27 2.22 ± 1.33 2.21 ± 1.26
Total mean 2.96 ± 1.04 2.38 ± 1.11 2.39 ± 1,45
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to approximately determining tears secretion. 14 The 
production of tears from the lacrimal gland, tear distribution 
over the cornea by blinking, evaporation of tears from the 
ocular surface and drainage through the nosolacrimal duct 
are the processes that tears undergo. 15 The quantity of tears 
on these tissues at any given time is essential for ocular 
health. Abnormalities in the course of the tear film may 
result in eye conditions that can be detrimental to vision. 
Therefore the production or the stimulation of the lacrimal 
gland to produce more tears may be an essential step in 
addressing tears related problems. Thus pilocarpine was 
employed to stimulate tears secretion.
The major complaints after the application of the 
parasympathomimetic agents were constricted pupil, red eyes 
and stinging sensation and were observed in higher proportion 
in the groups of age between 10 to 30 years of age. Transient 
blurred vision, and reduced pupil sizes in the volunteers as a 
result of the drugs were common observations among the 
participants. There was no other major adverse effect of 
pilocarpine observed during the period of study. However, 
subjects above 32 years of age showed slight reduction of their 
pupil sizes and were more tolerant or had no stinging effect of 
the drug. There were no signi cant differences between the 
mean pupil sizes observed after the instillation of 2 % and 4 % 
pilocarpine concentrations (Critical t = 1.96 and calculated 
t = 1.83), using two tailed t test at 0.05 con dence level.
The mean (initial) basal tear  ow rate showed no signi cant 
differences between the male and the female participants 
(Critical t = 1.96 and calculated t = 1.72). The study revealed 
signi cant differences between the initial mean tear  ow rate 
(IMTFR) value and the mean tear flow rate value after the 
administration of 2 % pilocarpine. (Critical t = 1.98 and calculated 
t = 6.46), using t test statistics. There were also significant 
differences between 2 % and 4 % pilocarpine mean tear  ow rate 
values. (Critical t = 1.96 and calculated t = 3.41). Therefore, 
there was an increase in the observed tear  ow rate with topical 
pilocarpine. This observation was similar to the one reported by 
Vivino et al. 4 that pilocarpine increased the secretion of tears. 
There were no observed signi cant differences between the 
males and females tear  ow rates in the study. Lambert et al. 9 
also observed no signi cant differences in the mean tear  ow 
rate values between the males and the females.
The mean tear  ow rate values obtained after the instil-
lation of 4 % pilocarpine revealed no signi cant differences 
between the subjects in 10 to 20 and 40 to 50 years groups of 
age. This showed that 4 % pilocarpine bridged the gap between 
the mean tear  ow rate values of the youths (10 to 20 years) 
and the older adults (31-50 years). Although there were no 
signi cant differences between 2 % and 4 % concentrations of 
pilocarpine in stimulating tear production. It was observed 
that the mean tear  ow rates were adequate (14.25 mm) for 
all the age groups after the instillation of 4 % pilocarpine.
The initial mean tear flow rate values revealed that the 
group of age from 10 to 20 years had higher IMTFR values than 
subjects in the 41 to 50 years group and the differences were 
statistically significant (Critical t = 1.71 and calculated 
t = 3.08), using a two-tailed t test statistics. This agreed with 
the study carried out by Zintz and Schilling 16 and other 10-12,14,17 
on the relationship between tear secretions with age. The 
differences in the initial mean tear  ow rate values for the 
group of age from 10 to 20 years and the mean tear  ow rate 
values obtained after the instillation of 2 % pilocarpine in the 
group of age from 41 to 50 were statistically negligible (Critical 
t = 1.96 and calculated t = 0.18). Therefore, 2 % pilocarpine 
may be adequate in stimulating increased tear production 
particularly in the groups of age from 31years and above.
It may be necessary to carry out further studies on the 
stimulating effects of topical pilocarpine on tear secretion 
and on dry eye patients, resulting from insufficient tear 
secretion. However, in this study, it can be concluded that 
tear flow rate decreases with advancing age and topical 
pilocarpine is useful in increasing the tear  ow rate in the 
aging healthy eye of the black population.
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